Deutsche Bank Reiterates a 'Buy' on Onyx Pharmaceuticals (ONXX); Expert Weigh In on DECISION
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $85.54 -3.67%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade ONXX Now!
Deutsche Bank reiterates a 'Buy' on Onyx Pharmaceuticals (NASDAQ: ONXX) price target of $77.00.
Analyst, Navdeep Singh, said, "In preparation for the phase 3 DECISION results, we hosted an expert call for clients. DECISION is evaluating Nexavar vs. placebo in points w/ thyroid cancer that is refractory to radioactive iodine. Given our conversation with expert & prior phase 2 data, we believe this opportunity is underappreciated. Onyx expects top-line data in H2:12. We expect data in Q3:12. Since investors do not assign much value to DECISION, we see limited downside risk into top-line."
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $67.24 yesterday, with a 52 week range of $27.17-$68.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Navdeep Singh, said, "In preparation for the phase 3 DECISION results, we hosted an expert call for clients. DECISION is evaluating Nexavar vs. placebo in points w/ thyroid cancer that is refractory to radioactive iodine. Given our conversation with expert & prior phase 2 data, we believe this opportunity is underappreciated. Onyx expects top-line data in H2:12. We expect data in Q3:12. Since investors do not assign much value to DECISION, we see limited downside risk into top-line."
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $67.24 yesterday, with a 52 week range of $27.17-$68.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Kyprolis Sales On-Track (ONXX) - Jefferies
- UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
- UPDATE: Macquarie Downgrades Sprint (S) to Neutral
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Deutsche Bank
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
